FDA Offers Advice to Sponsors of ADHD Drugs

Drug Industry Daily
A A
The FDA released a draft guidance for sponsors of stimulant drugs for treating attention deficit hyperactivity disorder (ADHD) with recommendations for clinical trials and new drug applications.

To View This Article:

Login

Subscribe To Drug Industry Daily